バッケムジャパン株式会社

【Bachemウェビナー 3月16日17時~】"Chemo Enzymatic Ligation – A New Tool for The Synthesis of Long and Cyclic Peptides as well as (Bio)Conjugates"

2021/03/15

開催日 2021年3月16日(火)
開催地 Web

【開催日時】 2022年3月16日(火) 17:00~18:00(60分間)

【参加費】  無料(事前登録制)

【受講方法】 オンライン
下記リンク(”セミナーホームページを見る”)より事前登録をお願い致します。

  <トピックス>
Bachem is excited to be hosting Enzytag as a speaker for our latest webinar, showing how peptiligases enable a more economical manufacturing of specific linear and cyclic peptide drugs as well as (bio)conjugates. Bachem has unique capabilities in the area of solid phase, hybrid, and solution phase peptide chemistry of therapeutic peptides. We are passionate about innovation with a strong focus on realizing value in all areas of the company. As we are convinced that Enzytag’s innovative technology offers substantial advantages regarding efficiency, and towards greener manufacturing, we are proud to host them for this webinar. Learn about the basics of their peptide synthesis technology (“Chemo Enzymatic Peptide Synthesis” or “CEPS”) in this webinar presented by Dr. Leendert van den Bos, the Co-Founder at Enzytag. Interested?

<スピーカー>  Leendert van den Bos, Ph.D. Co-Founder at Enzytag
Dr. Leendert van den Bos obtained his M.Sc.- and Ph.D.-degree in bio-organic chemistry from Leiden University. In 2007, he joined Organon BioSciences as a Scientist and worked subsequently for Schering-Plough, Merck Sharp & Dohme and Aspen Pharmacare mostly in the field of Process Research & Development. In 2018 he co-founded EnzyTag focusing on the development of chemo-enzymatic processes for complex peptide API’s. Leendert holds an Executive MBA from Nyenrode University.

<モデレーター> Seamus White, Business Development Manager at BachemSeamus
White is a Business Development Manager at Bachem Bubendorf. He is located in Northern Ireland and is the primary contact for our partners in the UK and Ireland in the area of GMP peptide API manufacture and development. In his role, he supports our customers through all phases of their project - from preclinical research and IND enabling toxicology studies to process validation and commercialization. Seamus has been with Bachem since 2020, and prior to this he held positions in Global Procurement, Supplier Management, Lead Auditor and also has API Development and Manufacturing experience with a major Pharma. He has a Bachelor’s degree in Chemistry with Pharmacology and is a chartered Procurement Professional.

企業情報

バッケムジャパン株式会社

詳しく見る

TOP